Reports - Recombinant DNA Technology Market
Technology & MediaRecombinant DNA Technology Market
Recombinant DNA Technology Market Valuation and Growth Forecast 2025-2035 by Products (Medical, Non-Medical), by Components (Expression System, Cloning Vector), by Applications (Food & Agriculture, Health & Disease, Environment, Other Applications), by End Users (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other End Users), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Recombinant DNA Technology Market - Segment Analysis
1. Overview
2. Global Recombinant DNA Technology Market, 2019 - 2030 (USD Million)
3. Global Recombinant DNA Technology Market - by Products
3.1. By Medical
3.2. By Non-Medical
4. Global Recombinant DNA Technology Market - by Components
4.1. By Expression System
4.2. By Cloning Vector
5. Global Recombinant DNA Technology Market - by Applications
5.1. By Food & Agriculture
5.2. By Health & Disease
5.3. By Environment
5.4. By Other Applications
6. Global Recombinant DNA Technology Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Academic & Government Research Institutes
6.3. By Other End Users
7. Global Recombinant DNA Technology Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Recombinant DNA Technology Market - Segment Analysis
1. Overview
2. North America Recombinant DNA Technology Market, 2019 - 2030 (USD Million)
3. North America Recombinant DNA Technology Market - by Products
3.1. By Medical
3.2. By Non-Medical
4. North America Recombinant DNA Technology Market - by Components
4.1. By Expression System
4.2. By Cloning Vector
5. North America Recombinant DNA Technology Market - by Applications
5.1. By Food & Agriculture
5.2. By Health & Disease
5.3. By Environment
5.4. By Other Applications
6. North America Recombinant DNA Technology Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Academic & Government Research Institutes
6.3. By Other End Users
Chapter 5 Europe Recombinant DNA Technology Market - Segment Analysis
1. Overview
2. Europe Recombinant DNA Technology Market, 2019 - 2030 (USD Million)
3. Europe Recombinant DNA Technology Market - by Products
3.1. By Medical
3.2. By Non-Medical
4. Europe Recombinant DNA Technology Market - by Components
4.1. By Expression System
4.2. By Cloning Vector
5. Europe Recombinant DNA Technology Market - by Applications
5.1. By Food & Agriculture
5.2. By Health & Disease
5.3. By Environment
5.4. By Other Applications
6. Europe Recombinant DNA Technology Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Academic & Government Research Institutes
6.3. By Other End Users
Chapter 6 Asia Pacific Recombinant DNA Technology Market - Segment Analysis
1. Overview
2. Asia Pacific Recombinant DNA Technology Market, 2019 - 2030 (USD Million)
3. Asia Pacific Recombinant DNA Technology Market - by Products
3.1. By Medical
3.2. By Non-Medical
4. Asia Pacific Recombinant DNA Technology Market - by Components
4.1. By Expression System
4.2. By Cloning Vector
5. Asia Pacific Recombinant DNA Technology Market - by Applications
5.1. By Food & Agriculture
5.2. By Health & Disease
5.3. By Environment
5.4. By Other Applications
6. Asia Pacific Recombinant DNA Technology Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Academic & Government Research Institutes
6.3. By Other End Users
Chapter 7 Latin America Recombinant DNA Technology Market - Segment Analysis
1. Overview
2. Latin America Recombinant DNA Technology Market, 2019 - 2030 (USD Million)
3. Latin America Recombinant DNA Technology Market - by Products
3.1. By Medical
3.2. By Non-Medical
4. Latin America Recombinant DNA Technology Market - by Components
4.1. By Expression System
4.2. By Cloning Vector
5. Latin America Recombinant DNA Technology Market - by Applications
5.1. By Food & Agriculture
5.2. By Health & Disease
5.3. By Environment
5.4. By Other Applications
6. Latin America Recombinant DNA Technology Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Academic & Government Research Institutes
6.3. By Other End Users
Chapter 8 Middle East & Africa Recombinant DNA Technology Market - Segment Analysis
1. Overview
2. Middle East & Africa Recombinant DNA Technology Market, 2019 - 2030 (USD Million)
3. Middle East & Africa Recombinant DNA Technology Market - by Products
3.1. By Medical
3.2. By Non-Medical
4. Middle East & Africa Recombinant DNA Technology Market - by Components
4.1. By Expression System
4.2. By Cloning Vector
5. Middle East & Africa Recombinant DNA Technology Market - by Applications
5.1. By Food & Agriculture
5.2. By Health & Disease
5.3. By Environment
5.4. By Other Applications
6. Middle East & Africa Recombinant DNA Technology Market - by End Users
6.1. By Biotechnology & Pharmaceutical Companies
6.2. By Academic & Government Research Institutes
6.3. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. F. Hoffmann-La Roche Ltd (Genentech Inc)
2. Profacgen
3. Amgen Inc
4. Novartis AG
5. GenScript
6. Pfizer Inc
7. Novo Nordisk A/S
8. Eli Lilly and Company
9. Sanofi Merck & Co. Inc.
10. Biogen
11. Biocon
12. GlaxoSmithKline PLC
13. New England Biolabs
14. Cibus
15. Monsanto Company
16. Horizon Discovery Group PLC
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By